Klinik Araştırma

A New Beginning After Severe COVID-19: Long-Term Quality of Life Study

Cilt: 11 Sayı: 1 24 Ocak 2025
PDF İndir
TR EN

A New Beginning After Severe COVID-19: Long-Term Quality of Life Study

Öz

ABSTRACT Objective: The pandemic caused by coronavirus (2019-nCoV) overwhelmed the health systems and became an important cause of morbidity and mortality. It reduces health-related quality of life by causing long-term physical, mental and cognitive disorders. Our aim is to evaluate the long-term effects of COVID-19 on patients by assessing quality of life and respiratory functions of the patients with severe COVID-19 during hospital follow-up and one year after discharge. Material and Methods: This is a retrospective cross-sectional study. Data from the Nothingam Health Profile (NSP) questionnaire and the Modified Medical Research Council Scale (mMRC), which were administered to patients in person on the first day of their ICU discharge and again in person and via telemedicine at month 12, were scanned from the files. Wilcoxon Signed-Rank test was used for statistical analyses, p < .05 value was considered significant. Results: The patients’ mean scores according to the NHP scale were 29.5±37.6 for pain, 23.4±25.5 for emotional variables, 39±36.1 for sleep, 25±33.2 for social isolation, 65±33.7 for physical activity, 98.2±9.1 for energy, and the total score for part 1 was 280.3±95.1 (p ˂ .001). Although a statistically significant decrease was detected in the mean scores of the NHP scale at the 12th month, the increase remained. Conclusion: It is of great importance for public health that patients with COVID-19 are followed up and treated in terms of post-COVID syndrome.

Anahtar Kelimeler

Kaynakça

  1. 1) WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data). http//www.covid19.who.int. Access date: 23 December 2022.
  2. 2) Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8(5):475-81. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020;8(4):e26. PMID: 32105632; PMCID: PMC7102538.
  3. 3) Frota AX, Vieira MC, Soares CCS, Silva PSD, Silva GMSD, Mendes FSNS, Mazzoli-Rocha F, Veloso HH, Costa ADD, Lamas CDC, Valete-Rosalino CM, Gonçalves TR, Costa HS, Rodrigues Junior LF, Mediano MFF. Functional capacity and rehabilitation strategies in Covid-19 patients: current knowledge and challenges. Rev Soc Bras Med Trop 2021; 54:e07892020.
  4. 4) Venkatesan P. NICE guideline on long COVID. Lancet Respir Med 2021; 9(2):129.
  5. 5) Heesakkers H, van der Hoeven JG, Corsten S, Janssen I, Ewalds E, Simons KS, Westerhof B, Rettig TCD, Jacobs C, van Santen S, Slooter AJC, van der Woude MCE, van den Boogaard M, Zegers M. Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. JAMA 2022; 327(6):559-65.
  6. 6) Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS; Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348(8):683-93.
  7. 7) WHOQOL - Measuring Quality of Life| The World Health Organization. http//www.eho.int. Access date: 23 December 2022.
  8. 8) Hunt SM, McEwen J, McKenna SP. Measuring Health Status: A New Tool For Clinicians and Epidemiologists. The Journal of the Royal College of General Practitioners 1985; 35(273):185-8.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Bulaşıcı Hastalıklar

Bölüm

Klinik Araştırma

Erken Görünüm Tarihi

20 Ocak 2025

Yayımlanma Tarihi

24 Ocak 2025

Gönderilme Tarihi

14 Aralık 2023

Kabul Tarihi

5 Mayıs 2024

Yayımlandığı Sayı

Yıl 2025 Cilt: 11 Sayı: 1

Kaynak Göster

APA
Berik Safçi, S., Yaşa Öztürk, G., & Salcan, T. (2025). A New Beginning After Severe COVID-19: Long-Term Quality of Life Study. Akdeniz Tıp Dergisi, 11(1), 49-55. https://doi.org/10.53394/akd.1404770
AMA
1.Berik Safçi S, Yaşa Öztürk G, Salcan T. A New Beginning After Severe COVID-19: Long-Term Quality of Life Study. Akd Tıp D. 2025;11(1):49-55. doi:10.53394/akd.1404770
Chicago
Berik Safçi, Sinem, Gülşah Yaşa Öztürk, ve Tarık Salcan. 2025. “A New Beginning After Severe COVID-19: Long-Term Quality of Life Study”. Akdeniz Tıp Dergisi 11 (1): 49-55. https://doi.org/10.53394/akd.1404770.
EndNote
Berik Safçi S, Yaşa Öztürk G, Salcan T (01 Ocak 2025) A New Beginning After Severe COVID-19: Long-Term Quality of Life Study. Akdeniz Tıp Dergisi 11 1 49–55.
IEEE
[1]S. Berik Safçi, G. Yaşa Öztürk, ve T. Salcan, “A New Beginning After Severe COVID-19: Long-Term Quality of Life Study”, Akd Tıp D, c. 11, sy 1, ss. 49–55, Oca. 2025, doi: 10.53394/akd.1404770.
ISNAD
Berik Safçi, Sinem - Yaşa Öztürk, Gülşah - Salcan, Tarık. “A New Beginning After Severe COVID-19: Long-Term Quality of Life Study”. Akdeniz Tıp Dergisi 11/1 (01 Ocak 2025): 49-55. https://doi.org/10.53394/akd.1404770.
JAMA
1.Berik Safçi S, Yaşa Öztürk G, Salcan T. A New Beginning After Severe COVID-19: Long-Term Quality of Life Study. Akd Tıp D. 2025;11:49–55.
MLA
Berik Safçi, Sinem, vd. “A New Beginning After Severe COVID-19: Long-Term Quality of Life Study”. Akdeniz Tıp Dergisi, c. 11, sy 1, Ocak 2025, ss. 49-55, doi:10.53394/akd.1404770.
Vancouver
1.Sinem Berik Safçi, Gülşah Yaşa Öztürk, Tarık Salcan. A New Beginning After Severe COVID-19: Long-Term Quality of Life Study. Akd Tıp D. 01 Ocak 2025;11(1):49-55. doi:10.53394/akd.1404770